Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 11 open reading frame 97 (C11orf97, also known as LINC01171) encodes a short, uncharacterized human protein of 126 amino acids (~13.9 kDa), with predicted localization in the cytoplasm and potential shuttling to and from the nucleus[5]. Its gene is located on chromosome 11q21. The protein features no known transmembrane regions or established protein domains, but is subject to various post-translational modifications including phosphorylation and sumoylation[5][2]. C11orf97 is expressed across many tissues but is most highly detected in several brain regions and lung tissue[5][1]. Evidence from protein-protein interaction data suggests possible roles in cellular stress responses, protein ubiquitination, and transcriptional regulation, although its precise biological function is not well defined[2][5]. Some studies link its potential involvement to rare pathological conditions such as Lemierre’s syndrome and hepatic coma, mainly by association with interacting proteins rather than direct evidence[5]. No therapeutic drugs or biomarker roles have been reported, and there are currently no recognized safety or toxicity concerns. Key points: - The gene is protein-coding and encodes a small, evolutionarily conserved, but uncharacterized protein[1][5]. - Sometimes referenced as LINC01171, it is occasionally annotated as a non-coding RNA but is more accurately described as a protein-coding gene in major databases[1][5]. - It is not established as a therapeutic target, drug target, or direct disease biomarker[1][7]. - Molecular function remains largely unknown; possible indirect disease links are speculative and not well validated[5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 11 open reading frame 97 (C11orf97).